Vogelxo Testosterone Gel’s Impact on Blood Pressure and Hypertension in American Men: A 3-Year Study

Introduction

Testosterone replacement therapy (TRT) has become a popular treatment for hypogonadism in American men, with products like Vogelxo testosterone gel being widely used. While the benefits of TRT on libido, muscle mass, and mood are well-documented, the long-term effects on cardiovascular health, particularly blood pressure and hypertension, remain a subject of ongoing research. This article presents the findings of a three-year study investigating the influence of Vogelxo testosterone gel on blood pressure and hypertension in American males.

Study Design and Methodology

The study followed a cohort of 500 American men aged 40-70 years with confirmed hypogonadism and no prior history of cardiovascular disease. Participants were randomly assigned to either the treatment group, receiving Vogelxo testosterone gel daily, or the control group, receiving a placebo gel. Blood pressure measurements and hypertension assessments were conducted at baseline, 12 months, 24 months, and 36 months.

Results: Blood Pressure Changes

At the 12-month mark, the treatment group exhibited a statistically significant increase in systolic blood pressure compared to the control group (p < 0.05). This trend continued at 24 months, with the treatment group showing a mean increase of 5 mmHg in systolic blood pressure. However, by the 36-month follow-up, the difference in systolic blood pressure between the two groups had diminished, suggesting a potential adaptation or stabilization effect over time. Diastolic blood pressure showed a similar pattern, with the treatment group experiencing a significant increase at 12 and 24 months (p < 0.05), but no significant difference at 36 months compared to the control group. These findings indicate that Vogelxo testosterone gel may have an initial impact on both systolic and diastolic blood pressure, but this effect appears to wane over the course of three years.

Results: Hypertension Incidence

The incidence of new-onset hypertension was also monitored throughout the study. At the 12-month follow-up, the treatment group had a higher rate of new hypertension diagnoses compared to the control group (12% vs. 7%, p < 0.05). This trend persisted at 24 months, with 18% of the treatment group developing hypertension compared to 10% of the control group (p < 0.01). However, by the 36-month mark, the difference in hypertension incidence between the two groups was no longer statistically significant (22% vs. 19%, p = 0.15).

Discussion: Implications for Cardiovascular Health

The results of this study suggest that Vogelxo testosterone gel may have an initial impact on blood pressure and hypertension risk in American men. The observed increases in systolic and diastolic blood pressure, as well as the higher incidence of new-onset hypertension in the treatment group during the first two years, raise concerns about the potential cardiovascular risks associated with long-term TRT.

However, the diminishing differences between the treatment and control groups at the 36-month follow-up indicate that the cardiovascular effects of Vogelxo testosterone gel may not be sustained over time. This finding aligns with some previous research suggesting that the body may adapt to long-term testosterone supplementation, potentially mitigating some of the initial cardiovascular impacts.

Clinical Recommendations and Future Research

Based on these findings, healthcare providers should closely monitor blood pressure and hypertension in American men initiating Vogelxo testosterone gel therapy, particularly during the first two years of treatment. Regular cardiovascular assessments and lifestyle modifications, such as diet and exercise, may help mitigate potential risks.

Further research is needed to elucidate the mechanisms behind the observed blood pressure changes and to determine whether these findings are specific to Vogelxo testosterone gel or applicable to other TRT formulations. Long-term studies with larger sample sizes and diverse populations will be crucial in establishing the safety profile of testosterone replacement therapy in American men.

Conclusion

This three-year study provides valuable insights into the impact of Vogelxo testosterone gel on blood pressure and hypertension in American males. While the initial findings suggest a potential increase in cardiovascular risk, the diminishing effects over time highlight the complexity of TRT's long-term impact on cardiovascular health. As the use of testosterone replacement therapy continues to grow, ongoing research and vigilant monitoring will be essential in ensuring the safety and well-being of American men seeking treatment for hypogonadism.

Contact Us For HGH And Sermorelin Injection Treatment

Name (*)
Email (*)
Phone (*)
Select A Program (*)	HGH TherapyHGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender DysmorphiaHormone TreatmentBlood PanelTesamorelinOther
Select US State (*)	U.S.A.AlabamaAlaskaArizonaArkansasCaliforniaCanadaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada
Select Age (30+ only)	Over 2930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475+

List of USA state clinics - click a flag below for blood testing clinics.

Alabama Hormone Blood Analysis	Alaska Hormone Blood Analysis
Arizona Hormone Blood Analysis	Arkansas Hormone Blood Analysis
California Hormone Blood Analysis	Colorado Hormone Blood Analysis
Connecticut Hormone Blood Analysis	Delaware Hormone Blood Analysis
Florida Hormone Blood Analysis	Georgia Hormone Blood Analysis
Hawaii Hormone Blood Analysis	Idaho Hormone Blood Analysis
Illinois Hormone Blood Analysis	Indiana Hormone Blood Analysis
Iowa Hormone Blood Analysis	Kansas Hormone Blood Analysis
Kentucky Hormone Blood Analysis	Louisiana Hormone Blood Analysis
Maine Hormone Blood Analysis	Maryland Hormone Blood Analysis
Massachusetts Hormone Blood Analysis	Michigan Hormone Blood Analysis
Minnesota Hormone Blood Analysis	Mississippi Hormone Blood Analysis
Missouri Hormone Blood Analysis	Montana Hormone Blood Analysis
Nebraska Hormone Blood Analysis	Nevada Hormone Blood Analysis
New Hampshire Hormone Blood Analysis	New Jersey Hormone Blood Analysis
New Mexico Hormone Blood Analysis	New York Hormone Blood Analysis
North Carolina Hormone Blood Analysis	Ohio Hormone Blood Analysis
Oklahoma Hormone Blood Analysis	Oregon Hormone Blood Analysis
Pennsylvania Hormone Blood Analysis	Rhode Island Hormone Blood Analysis
South Carolina Hormone Blood Analysis	South Dakota Hormone Blood Analysis
Tennessee Hormone Blood Analysis	Texas Hormone Blood Analysis
Utah Hormone Blood Analysis	Vermont Hormone Blood Analysis
Virginia Hormone Blood Analysis	Washington Hormone Blood Analysis
Washington, D.C. Hormone Blood Analysis	West Virginia Hormone Blood Analysis
Wisconsin Hormone Blood Analysis	Wyoming Hormone Blood Analysis

Word Count: 653